On June 16, 2023, it was revealed that Lakewood Asset Management LLC had acquired a new position in shares of DuPont de Nemours, Inc. during the fourth quarter of the previous year. According to the company’s recent 13F filing with the Securities and Exchange Commission (SEC), the institutional investor purchased 6,525 shares of the basic materials company’s stock worth approximately $448,000.
This development has sparked interest among investors and industry analysts who are eager to understand the implications of this purchase. It is no secret that DuPont de Nemours is a major player in the chemical industry, but what led Lakewood Asset Management LLC to make such a significant investment in this particular company?
DuPont de Nemours has recently been making headlines following reports of insider trading within the company. In May 2023, Michael G. Goss, an insider at DuPont de Nemours sold 2,374 shares of the company’s stock in a transaction valued at $155,402.04. Following this transaction, Goss now owns 13,345 shares in DuPont de Nemours worth approximately $873,563.70.
Despite these developments within the company, DuPont de Nemours opened at $69.73 on Friday with a market capitalization of $32.01 billion and boasts a P/E ratio of just 6.05. This is impressive given that it has a price-to-earnings-growth ratio of 2.48 and a beta value of 1.41.
The chemical industry can be highly competitive and subject to volatility but investing in companies like DuPont de Nemours requires an astute understanding of market trends and regulatory frameworks impacting the sector.
Lakewood Asset Management LLC’s decision to purchase shares in DuPont de Nemours demonstrates their confidence in both its value as an investment opportunity and its future prospects for growth despite internal challenges faced by the company. This move will no doubt prompt other investors to re-examine their portfolios and consider buying into DuPont de Nemours.
In summary, as a leading player in the chemical industry, DuPont de Nemours is poised to be a top investment choice for institutional investors like Lakewood Asset Management LLC. Despite concerns around insider trading, the company’s performance has remained strong, providing investors with a positive outlook for returns on their investments. These factors surely inspire confidence in investors looking to make good of opportunities presented by the chemical industry.
[bs_slider_forecast ticker=”DD”]
Increase in Institutional Investment and Positive Analyst Ratings for DuPont de Nemours Inc.
[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”DD” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]DuPont de Nemours Inc., a leading basic materials company, has seen an increased stake in its shares by notable institutional investors and hedge funds. Allstate Corp boosted its position in the third quarter, now owning 18,087 shares of the company’s stock. Fayez Sarofim & Co also grew its stake by 0.7% in the fourth quarter, with Oregon Public Employees Retirement Fund raising its holdings by 0.4%. Similarly, Kentucky Retirement Systems lifted its position and Carolinas Wealth Consulting LLC boosted their holdings during Q3. Institutional investors are holding 71.91% of the stock which may increase confidence and potential for high returns.
The company has been rated a “Moderate Buy” according to Bloomberg with analysts weighing in on DuPont’s financial performance. Recent reports have shown that DuPont’s return on equity is at 6.34% while recording a sizeable net margin of 43.63%, significantly higher than expected estimates from analysts.
Despite having reduced dividends, shareholders still benefitted last Thursday when DuPont declared a quarterly dividend payout of $1.44 per share, which represents an annualized yield of 2.07%. The dip in dividend payout ratio (DPR) has not harmed investors as they remain confident that the investment will pay off.
Insiders continue to invest in the company with Michael G.Goss selling over two thousand shares valued at $65 each this month – totaling $155,402 whilst James C.Collins Jr recently purchased additional stocks worth approximately $123286 through his wife’s account further solidifying confidence in DuPont’s future prospects.
Although price targets on DuPoint de Nemours have taken a slight hit after Barclays lowered their forecasting figures from $76 to $72; Deutsche Bank Aktiengesellschaft raised theirs from $70 to $80 and upgraded the rating to buy making it imperative that potential investors keep track of any changes that occur and proceed with caution.
